Document is current
Any future updates will be listed below
-
Authors
Zhao, Jian https://orcid.org/0009-0007-6536-2028
Dong, Yu https://orcid.org/0009-0005-8666-4426
Shi, Shuya https://orcid.org/0009-0004-8062-0628
Yu, Hongqiang https://orcid.org/0009-0007-9852-6068
Tan, Luanjun https://orcid.org/0009-0006-8766-3203
- License Information
-
More Information
Article History
Received: 23 November 2024
Accepted: 4 March 2025
First Online: 18 March 2025
Competing interests
: The authors declare no competing interests.
: The designed protocol (approval number: TU1524 dated 17 August 2017) was approved by the Affiliated Hospital of JiangNan University review board and the Shanghai East Hospital Affiliated to Tongji University review board and the Chinese Society of Clinical Oncology. The study followed the law of China and the v2008 Declarations of Helsinki. Written informed consent was obtained from all participating patients regarding participation in the study.
: Written informed consent was obtained from all participating patients regarding publication of manuscript (in one or more form).
